Sarepta Therapeutics (SRPT) option IV movement

Sarepta Therapeutics (NASDAQ: SRPT) 30-day option implied volatility is at 71; compared to its 52-week range of 39 to 144 amid the FDA informed Sarepta that it requires modest additional time to complete the review for Biologics License Application for SRP-9001, including final label negotiations and post marketing commitment discussions, and that it anticipates that the review will be complete by June 22.

You May Also Be Interested In

• GE HealthCare (GEHC) call put ratio 5.7 call to 1 put with a focus on July 31 weekly 68 calls
• Chipotle Mexican Grill (CMG) call put ratio 1.9 calls to 1 put into quarter results
• Qualcomm (QCOM) call put ratio 1 call to 1.7 puts into quarter results